Currently out of the existing stock ratings of Stephanie Davis, 129 are a BUY (53.97%), 86 are a HOLD (35.98%), 24 are a SELL (10.04%).

Stephanie Davis

Work Performance Price Targets & Ratings Chart

Analyst Stephanie Davis, currently employed at BARCLAYS, carries an average stock price target met ratio of 74.38% that have a potential upside of 18.37% achieved within 258 days.

Stephanie Davis’s has documented 465 price targets and ratings displayed on 42 stocks. The coverage is on Healthcare, Technology, Consumer Cyclical, Communication Services sectors.

Most recent stock forecast was given on DOCS, Doximity at 14-May-2026.

Wall Street Analyst Stephanie Davis

Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for ACCD (ACCOLADE ) at 7/27/2020. The price target of $34 was fulfilled within 1 day with a profit of $1.19 (3.38%) receiving and performance score of 33.82.

Average potential price target upside

of $44.49 (54.59%) on INO (INOVIO PHARMACEUTICALS).
of $40.29 (17.8%) on COR (CENCORA).
of $39.76 (19.92%) on VEEV (VEEVA SYSTEMS).

ACCD Accolade CERN Cerner Corp CPSI Computer Programs and Systems GDRX Goodrx Holdings HMSY HMS Holdings Corp HQY HealthEquity INOV Inovalon Holdings MDRX Allscripts Healthcare Solutions PHR Phreesia RCM R1 RCM TALK Talkspace TRHC Tabula Rasa HealthCare VCRA Vocera Communications VEEV Veeva Systems NUAN Nuance Communications NXGN Nextgen Healthcare PINC Premier TDOC Teladoc DOCS Doximity HCAT Health Catalyst ATHN athenahealth CHNG Change Healthcare EVH Evolent Health LVGO Livongo Health CAH Cardinal Health COR Cencora DGX Quest Diagnostics LFST Lifestance Health Group LH Laboratory of America Holdings OMCL Omnicell OPRX OPTIMIZERx Corp WBA Walgreens Boots Alliance WW WW International CDK CDK Global Holdings LLC MD Mednax PGNY Progyny WB Weibo Corp INO Inovio Pharmaceuticals NU Nu Holdings Ltd RC Ready Capital Corp SDC SmileDirectClub VC Visteon Corp

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Jeff Garro (STEPHENS)